glp-1 drugs ro Agonists Explained: Definition, How They Work, Side Effects ro glp 1 Get access

Compelling evidence from landmark clinical trials, particularly STEP-HFpEF, STEP-HFpEF DM and SUMMIT, has established the efficacy of GLP-1RAs in improving HF-related symptoms and quality of life, as well as reducing worsening HF events, in the prevalent phenotype of HFpEF in the setting of obesity and T2D

Exploring these alternative methods opens the door for potential key clinical differentiation from competitors

Important patient-level data such as comorbidities, concurrent medications, and timing of symptom onset are often missing

Prescribing authority was relatively concentrated, and decision-making followed established clinical algorithms

Avoiding high-fat and spicy foods and ensuring adequate fluid intake can also be beneficial

Metab 46 , 101090 (2020)